article thumbnail

Behind the Buds: Examining Job Conditions in the Cannabis Cultivation Industry

Veriheal

In January 2022, a devastating incident shook the U.S. She received asthma treatment, although she had no history of the condition. By January 2022, her respiratory issues had worsened. Do not attempt to self-diagnose or prescribe treatment based on the information provided. cannabis cultivation industry.

article thumbnail

Press Release: Red Light Holland and Advocacy Group Psychedelic Medicine Alliance Washington Celebrate the Success of their Collaboration as Washington Legislature Funds Psilocybin Wellness Workgroup

Cannabis Law Report

March 12, 2022. ? – March 11, 2022) – Red Light Holland Corp. – March 11, 2022) – Red Light Holland Corp. Washington legislators fund $200,000 USD for a Psilocybin Wellness Workgroup to research and write a report that will inform a pathway for future legislation. ? Toronto, Ontario–(Newsfile Corp.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

With its abundance of medicinal properties and non-addictive nature, why does marijuana remain an untapped resource for researchers wanting to find treatments for debilitating chronic diseases like Parkinson’s? As a result, cannabis advocacy groups urged the agency to recognize cannabis’ medicinal value and treat it equally.

DEA 98
article thumbnail

Press Release: PAREA: A new psychedelic-focused alliance of prominent companies with common goals

Cannabis Law Report

The Multi-organization psychedelic partnership is set to launch on June 23 2022. The Psychedelic Access and Research European Alliance (PAREA) is a group founded in 2022 and comprised of 15 organizations with common goals in the field of mental health and psychedelics. — Pain Alliance Europe (@pain_europe) June 10, 2022.

Therapy 52
article thumbnail

Press Release: COMPASS Pathways appoints Kabir Nath as Chief Executive Officer

Cannabis Law Report

London, UK July 19, 2022. COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022.

Therapy 52
article thumbnail

Rhode Island House Greenlights Psilocybin Legalization, Paving the Way for Therapeutic Access

Veriheal

If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments. His advocacy brings the drug reform movement to Capitol Hill. ” Recently, Sen.

Access 97
article thumbnail

MAPS – Position: State Government Affairs Lead – Remote

Cannabis Law Report

MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.